These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21411384)

  • 1. Microvascular complications and risk factors in patients with type 2 diabetes.
    Del Cañizo Gómez FJ; Fernández Pérez C; Moreno Ruiz I; de Gorospe Pérez-Jáuregui C; Silveira Rodríguez B; González Losada T; Segura Galindo A
    Endocrinol Nutr; 2011 Apr; 58(4):163-8. PubMed ID: 21411384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes.
    Park JY; Kim HK; Chung YE; Kim SW; Hong SK; Lee KU
    Diabetes Care; 1998 Apr; 21(4):530-4. PubMed ID: 9571337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes.
    Tong PC; Lee KF; So WY; Ng MH; Chan WB; Lo MK; Chan NN; Chan JC
    Diabetes Care; 2004 Jan; 27(1):216-22. PubMed ID: 14693992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between plasma fibrinogen levels and microvascular complications in type 2 diabetes.
    ; Ahmad I; ; Ali M; Hussain M;
    J Pak Med Assoc; 2024 Aug; 74(8):1441-1448. PubMed ID: 39160710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
    Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
    Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.
    Lv WS; Sun RX; Gao YY; Wen JP; Pan RF; Li L; Wang J; Xian YX; Cao CX; Zheng M
    World J Gastroenterol; 2013 May; 19(20):3134-42. PubMed ID: 23716995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism.
    Johnson L; Rayner B
    Cardiovasc J Afr; 2020 Jan/Feb 23; 31(1):5-8. PubMed ID: 31469387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular complications and their associated risk factors in type 2 diabetes mellitus.
    Khanam PA; Hoque S; Begum T; Habib SH; Latif ZA
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S577-S581. PubMed ID: 28455164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus?
    Herrera-Pombo JL; Aguilar-Diosdado M; Hawkins F; Campos MM; Moreno A; Garcia-Hernandez A; Castro E; García-Doncel LG; Serraclara A; Sánchez-Malo C; Escobar-Jiménez F
    Nephron Clin Pract; 2005; 101(3):c116-21. PubMed ID: 16015000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus.
    Müller M; Schönfeld CL; Grammer T; Krane V; Drechsler C; Genser B; Kohnen T; Wanner C; März W
    Sci Rep; 2020 Aug; 10(1):14158. PubMed ID: 32843669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
    Greaves M; Malia RG; Goodfellow K; Mattock M; Stevens LK; Stephenson JM; Fuller JH
    Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of cardiovascular disease in patients with Type 2 diabetes. 6.3 years of follow-up.
    Rius Riu F; Salinas Vert I; Lucas Martín A; Romero González R; Sanmartí Sala A
    J Diabetes Complications; 2003; 17(5):235-42. PubMed ID: 12954150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden and pattern of micro vascular complications in type 2 diabetes in a tertiary health institution in Nigeria.
    Olamoyegun M; Ibraheem W; Iwuala S; Audu M; Kolawole B
    Afr Health Sci; 2015 Dec; 15(4):1136-41. PubMed ID: 26958014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical factors associated with urinary albumin excretion in type II diabetes.
    Savage S; Nagel NJ; Estacio RO; Lukken N; Schrier RW
    Am J Kidney Dis; 1995 Jun; 25(6):836-44. PubMed ID: 7771479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications.
    Bashir M; Elhadd T; Dabbous Z; Gul W; Salameh O; Siddiqui M; Al-Muhannadi H; Petropoulos I; Khan A; Ponirakis G; Malik RA
    Diabetes Metab Syndr; 2021; 15(5):102241. PubMed ID: 34390975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
    Sacks FM; Hermans MP; Fioretto P; Valensi P; Davis T; Horton E; Wanner C; Al-Rubeaan K; Aronson R; Barzon I; Bishop L; Bonora E; Bunnag P; Chuang LM; Deerochanawong C; Goldenberg R; Harshfield B; Hernández C; Herzlinger-Botein S; Itoh H; Jia W; Jiang YD; Kadowaki T; Laranjo N; Leiter L; Miwa T; Odawara M; Ohashi K; Ohno A; Pan C; Pan J; Pedro-Botet J; Reiner Z; Rotella CM; Simo R; Tanaka M; Tedeschi-Reiner E; Twum-Barima D; Zoppini G; Carey VJ
    Circulation; 2014 Mar; 129(9):999-1008. PubMed ID: 24352521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of diabetic retinopathy, ischemic heart disease, and albuminuria with diabetic treatment in type 2 diabetic patients. A population-based study.
    Weitzman S; Maislos M; Bodner-Fishman B; Rosen S
    Acta Diabetol; 1997 Dec; 34(4):275-9. PubMed ID: 9451472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-onset type 2 diabetes: A high-risk factor for proliferative diabetic retinopathy (PDR) in patients with microalbuminuria.
    Lv X; Ran X; Chen X; Luo T; Hu J; Wang Y; Liu Z; Zhen Q; Liu X; Zheng L; Tang Y; Zhao Q; Han S; Zhou Y; Luo W; Yang L; Li Q; Wang Z
    Medicine (Baltimore); 2020 May; 99(19):e20189. PubMed ID: 32384512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular benefits of hypertension and glucose control in type 2 diabetes.
    van Rensburg BW
    Cardiovasc J Afr; 2008; 19(4):179-80. PubMed ID: 18776957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.